March 10th, 2016

Remembering former Chairman & CEO, Ralph Larsen

Ralph Larsen

It is with great personal sadness that I inform you of the passing of former Johnson & Johnson Chairman and Chief Executive Officer Ralph Larsen.

Ralph began his career with Johnson & Johnson in 1962 as a trainee, and rose through the ranks in our company’s consumer and hospital supply businesses. In 1986, he was named Vice Chairman of Johnson & Johnson, and became the Chief Executive Officer and Chairman of the Board in 1989, where he remained for 13 years until his retirement in 2002.

During his tenure, the company benefitted greatly from his tremendous leadership. Ralph had a clear vision for the future of Johnson & Johnson, and he oversaw a period of significant growth and global expansion, highlighted by an aggressive series of mergers and acquisitions that today continue to generate a significant positive impact on our company. These include the acquisitions of Neutrogena, DePuy and Centocor, among many others.

He was also dedicated to global expansion. Through his leadership, Johnson & Johnson set its foundations in Russia and Eastern Europe, areas of the world that are vital to our growth and ability to meet the needs of patients and consumers worldwide.

As a steward of Our Credo, Ralph championed the Women’s Leadership Initiative at Johnson & Johnson, a program which today thrives in advancing the development of women leaders across our company.

Read More

March 10th, 2016

3 Simple Steps for Helping Your Baby Fall Asleep

By Liz Ozaist, Global Content Lab Editor-in-Chief

45,000. That’s how many babies Johnson’s® has studied in a quest to help moms and dads uncover the secret to getting those little ones to finally go to sleep.

Well, what if we told you that a simple, three-step bedtime ritual could help your baby not only fall asleep faster—but also stay asleep longer after just one week of trying out the routine?

Ready to give this slumber routine a spin, right?

To learn more, check out JOHNSON’S®: Tonight We Sleep™ infographic, which was created using expert insight from pediatricians and sleep specialists—and intel from sleepless parents clocking late nights from Brazil to India.

JOHNSON's: Tonight We Sleep

 


LizJNJLiz Ozaist is the global digital content lab editor-in-chief for Johnson & Johnson. She is a veteran print and digital content creator with a passion for storytelling.

 

 

 

 

Read More

March 8th, 2016

Johnson & Johnson Partners with Michelle Obama to Let Girls Learn

Johnson & Johnson is proud to be a partner-of-choice in joining Michelle Obama to support the #LetGirlsLearn Initiative, a program that is helping girls around the world attend and finish school. We will feature the initiative on our Donate a Photo app, raise funds through the Global Moms Relay and provide product and monetary donations of more than $200,000 over the span of two years.

Johnson & Johnson is dedicated to continuing our legacy of promoting the health and wellbeing of girls and women because when we invest in educating girls, we create stronger, healthier communities worldwide.

To find out more about Let Girls Learn, and our support of this initiative, see the infographic below:

LetGirlsLearn_IG_FINAL2

 

Read More

March 8th, 2016

My Mother’s Career Words of Wisdom: “Never Compromise on What You Want to Do”

By Jane Griffiths, Company Group Chairman, Janssen, the Pharmaceutical Companies of Johnson & Johnson, Europe, Middle East and Africa

In honor of International Women’s Day, Janssen executive Jane Griffiths shares the story behind her work/life balance mantra.

Jane GriffithsI have never felt that being a woman would stop me from getting to where I wanted to be. This might be a testament to my strong-willed personality, but it really reflects how I was raised.

Today, I am the first female Company Group Chairman of Janssen for Europe, the Middle East and Africa. How did I get here?

On International Women’s Day, I look back on my journey and feel blessed. It wasn’t always plain sailing, but it was definitely worth it.

Like many young girls, I admired my mother, especially for being one of the few women at the time to hold a degree in chemistry. This paved the way for my interest in science, and also fueled my conviction that, as a woman, I could achieve all I wanted to—conventional or not.

As my mother always said: Never compromise on what you want to do.

When I started in the pharmaceutical industry it was a rather—but not exclusively—male-dominated environment. That said, my vocal and straight-talking personality did not go amiss!

Read More

March 7th, 2016

A Great Idea Can Come from Anywhere: How We Can Advance Innovation Through the Next Einstein Forum Global Gathering

By Seema Kumar, Vice President, Innovation, Global Public Health and Science Policy Communication

NEF

Can the next Einstein come from Africa? How about the next Pasteur or Curie? The answer is a resounding … yes!

It is a warm day in Dakar, Senegal, where I am currently engaged in the Next Einstein Forum Global Gathering, a celebration of African scientific talent and innovation that brings together heads of African governments, policy makers, media, NGOs, and companies like Johnson & Johnson.

African science is burgeoning and young African innovators are contributing new ideas to help solve serious health and technological challenges, from infectious disease medicines to health policies that can expand access to care.

The world needs more great talent working to find new preventive and curative solutions, and I was inspired after meeting some very impressive women working in science in African countries. They shared their remarkable stories of overcoming barriers to science education and mentorship—and what they are doing today to make a difference in the health of people in Africa and around the globe.

What we know from the success of our Johnson & Johnson Innovation centers is that a great idea can come from anywhere, and with the right support, new ideas can be nurtured and translated into meaningful advances in health.

Read More

March 7th, 2016

HIV: Why Combating the Virus Comes Down to Smart Collaborations

By Dr. Wim Parys, Vice-president, Head of R&D Global Public Health, Janssen Pharmaceutical Companies of Johnson & Johnson

The HIV virus continues to be one of the most complex global health challenges we face today—and one for which there is no single answer.

If we are to overcome HIV once and for all, we must develop, review and then adopt a variety of strategies and approaches to help ensure that the tremendous innovation efforts happening around the globe reach those in the greatest need.

As the head of the research and development team for the Global Public Health Group at Janssen, I feel compelled to not only continue to search for innovative and effective solutions—but to also seek strategic partnerships, whether it’s through collaborations between industry and non-profit organizations, public-private partnerships, or some combination of both.

We need to be as open-minded about how we work together as we have been about sourcing novel interventions.

One such partnership is a collaboration in place between Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the International Partnership for Microbicides (IPM), to help develop ways to deliver our highly potent antiretroviral (ARV) to populations in need.

A key focus for us over the last couple of years has been to help protect women in sub-Saharan Africa from contracting HIV.

Read More

March 4th, 2016

Johnson & Johnson Innovation LLC Debuts Its Latest Project: JLABS @ TMC

By Ryan McCoy

 Take a mini virtual tour of the fifth JLABS facility to open in the U.S. in Texas.

JLABS Open Work Space

Open work space at JLABS TMC

As the saying goes, everything’s bigger in Texas—including Johnson & Johnson Innovation LLC’s newest offshoot, JLABS @ TMC, which opens its doors this week at the Texas Medical Center in Houston.

The 34,000-square-foot life sciences incubator—the fifth JLABS facility to debut in the U.S.—will provide up to 50 up-and-coming startups innovating in the heathcare space with everything from private offices to modular laboratory suites decked out with state-of-the-art equipment.

“JLABS @ TMC enhances our already robust ecosystem of talented entrepreneurs who are solving the greatest unmet healthcare needs of our generation,” said Robert C. Robbins, M.D., president and CEO of the Texas Medical Center. “TMC has spent decades making healthcare history, and now these [startups] housed at TMC will take innovation to new heights.”

So what is it like to actually work inside such an innovative space? Take our mini virtual tour.

The Prototype Lab

JLABS Prototype Lab

JLABS @ TMC is the first JLABS facility to house a medical device prototype lab, featuring lab equipment, electronic testing and assembly process equipment, and such specialized software as 3D printers to better help entrepreneurs design and develop smart technologies

Tissue Culture and Private Cell Culture Facilities

These spaces feature a bevy of state-of-the-art equipment, including cell culture incubators, cold storage and oxygen control units catered to stem cell work.

These spaces feature a bevy of state-of-the-art equipment, including cell culture incubators, cold storage and oxygen control units catered to stem cell work

The Concept Lab

JLABS Concept Lab

This open environment lab is designed to grow with entrepreneurs who are starting out small, offering everything from environmental health and safety services to chemical inventory capabilities and even shipping and receiving assistance.

Read More

March 4th, 2016

Palm Oil Traceability: How Johnson & Johnson is Making Progress

By Paulette Frank, VP of Environment, Health, Safety & Sustainability for J&J Enterprise

Chances are you played a game known as telephone as a kid, where one child whispers a message to a friend, who then relays it to the next person in the chain, and so on until the last child in the group has to share the message out loud.

If you’ve participated in this game, you probably know that the more children who play, the harder it gets for the last child in the chain to successfully relay the original message.

I share this story because it has a lot in common with our experiences at Johnson & Johnson tracing the journey that some ingredients used in our personal care products take—but on a worldwide scale.

Making Personal Care Product Ingredients

Many personal care products contain ingredients such as emollients and emulsifiers that are made from palm oil and palm kernel oil. These ingredients are called “palm oil derivatives” and often go through multiple refining steps, with multiple suppliers, to meet the stringent requirements Johnson & Johnson expects. In the case of palm kernel oil, there is an additional step to crush the kernels, involving yet another supplier.

Read More

March 3rd, 2016

The Future for the DePuy Synthes Companies: How We Plan to Address Unmet Needs in Orthopaedics

By Juan Jose Gonzalez, President, DePuy Synthes U.S.

A leader at DePuy Synthes shares why it’s an exciting time to be innovating in the medical devices space.

AAOS BoothChances are you know someone who has broken a bone, or who’s dealt with a joint condition at some point in their lives.

In fact, musculoskeletal diseases affect more than one out of every two people over the age of 18, and nearly three out of four people aged 65 and older.*

Given that we have a growing population of people entering into their 60s, these conditions have the potential to place a greater burden on our healthcare system each year. At the same time, healthcare continues to change at a rapid pace, focusing more on providing comprehensive, high-quality care, while also keeping overall costs low.

For all of these reasons, it’s an interesting time to be working in orthopaedics.

This week, I’m at the American Academy of Orthopaedic Surgeon (AAOS) meeting. It’s my first time attending the event as President of the DePuy Synthes Companies in the United States. And while there are challenges today, there is also a significant opportunity to address unmet clinical needs in orthopaedics.

As part of the Johnson & Johnson Medical Devices group, we are in a unique position to help shape the future of the medical device industry for the benefit of patients, while also delivering greater value to our customers around the world.

Read More

March 2nd, 2016

Why I’m Proud to Work at Johnson & Johnson—a “Top 60 Companies for Executive Women” Award Winner

By Sandi Peterson, Group Worldwide Chairman, Johnson & Johnson

ASandi NAFE blogt the beginning of my career, I used to look around and realize that I was the only woman in the room.

So today’s news that, for the fifth year, Johnson & Johnson has garnered a top 10 spot on the National Association for Female Executives (NAFE) “Top 60 Companies for Executive Women” list, has a special significance for me.

Not only am I humbled to be part of a company that prides itself on supporting and promoting a diverse workforce, but I’m also grateful for the many women and men who’ve created a culture that makes this recognition possible.

The reality is that Johnson & Johnson has a strong history of diversification in the workplace dating back to 1886. At that time, the United States was heavily resistant to accepting women in the workplace. It was also the year that Johnson & Johnson was founded by a group of 14 employees—eight of whom were women.

Read more about our first women employees

This unprecedented beginning set the foundation for our progressive culture, where employees are encouraged to challenge the status quo and take risks.

Today, we also know something those founders didn’t: A diverse workforce actually makes for a healthier, more successful business.

Read More